Fig. 1From: Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation—a prospective, observational studyMPA exposure in relation to daily MMF intake. MPA exposure, defined by the variable MPA_AUC0–12 varied considerably between patients. Patients with anti-topoisomerase-1 antibodies had significantly lower drug exposure compared to the other subjectsBack to article page